Vendor, Newton, MA
Lumicell Inc.
UEI LKQGSHLAXVW5, CAGE 5RJY8
1 award and $399,036 obligated between September 9, 2024 and September 9, 2024, 100% under full and open competition, against 5.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $399,036 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Hear when Lumicell Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Lumicell Inc.'s contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,453,292 |
| Westat, Inc.Rockville, MD | $762,955,645 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91024C00081Definitive Contract, September 9, 2024, Full and Open Competition After Exclusion of Sources, 5 offers | NIH NCINational Institutes of Health | SBIR Topic 463: Clinical Evaluation for Early Detection of Esophageal Cancer with a Novel Fluorescence Endoscope and Pegulicianine, a Novel NAICS 541715, PSC AN12 | $399,036 |
- Places of performance
- Massachusetts
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards